During preparation of this manuscript for publication, errors were introduced into the abstract and introduction. The second sentence of the abstract incorrectly included the phrase "fewer than." The sentence should read: "We measured in vivo MTXPG accumulation in leukemia cells from 101 children with acute lymphoblastic leukemia (ALL) and established that B-lineage ALL with either TEL-AML1 or E2A-PBX1 gene fusion, or T-lineage ALL, accumulates significantly lower MTXPG compared with B-lineage ALL without these genetic abnormalities or compared with hyperdiploid (greater than 50 chromosomes) ALL."
"Subtypes with a relatively unfavorable prognosis on many treatment protocols include T-lineage ALL (T-ALL) and ALL with rearranged MLL genes or with BCR-ABL gene fusion, whereas ALL with either TEL-AML1 or E2A-PBX1 gene fusions, or hyperdiploid karyotypes (greater than 50 chromosomes), have a relatively good prognosis with most treatment protocols . . ."
We regret these errors.
Figure 5
AKBI mice have improved survival following I/R injury. AKBI or WT littermates either (A) received a lethal dose of LPS (4 μg/g body weight, i.v.) or (B) underwent partial lobar liver I/R. Survival was assessed for 14 days. Only times of survival are given for which deaths occurred. No deaths occurred past the plotted times. Survival curves were significantly different between AKBI and WT mice (P < 0.05) as assessed using the log-rank test.
